, announced a special worldwide license of the Melanoma Vaccine to The John P today. Hussman Basis, a charitable base that supports analysis to address life-threatening medical ailments and significant disabilities. BioSante received $100,000 on signing the permit and is qualified to receive up to $39 million in milestone obligations, plus royalties on product sales. Additionally, the Hussman Base has dedicated up to around $11 million in Melanoma Vaccine clinical development financing. Also, BioSante will receive between 15 and 33 % of any sublicense obligations received by the Hussman Base according to the timing of any sublicense by the building blocks to a corporate sub-licensee.Global Helps ambassador and assistant director-general of the WHO, writes in a New York Moments opinion piece responding to reports that the U.S. However vital it was to target Bin Laden, the covert use of a legitimate health program threatens to create U.S. Health and development aid an unintended casualty in the fight against terrorism. With an incredible number of lives being backed with U.S. Help, it is vital that medical attention to the needy continue without political hindrance and without trigger for impugning American humanitarian motives, he concludes . This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family members Foundation. Kaiser Health Information, an independent news service editorially, is a program of the Kaiser Family Foundation, a nonpartisan healthcare policy research organization unaffiliated with Kaiser Permanente..